Resources Archive

Filter:

Read more

Inflammation as a new target in CV risk reduction

“Lowering LCL-c is the first, second and third thing we have to do to lower atherosclerotic event rates, but what…

Read more

Professor Charalambos Antoniades, BHF Professor of Cardiovascular Medicine at the Radcliffe Department of Medicine, University of Oxford British Heart Foundation

7 Technologies That Could Change Heart Healthcare Forevermore

The advent of artificial intelligence (AI) and machine learning is making diagnosing and preventing deadly heart conditions much easier for…

Read more

Novel insights in inflammatory makers, AI, diagnostic tools and prediction of CV risk

This series consists of three educational videos. In the first lecture, Peter Libby discusses the role of inflammation in atherosclerosis….

Read more

Visualising Coronary Inflammation in CCTA: The Next Frontier for Cardiovascular Risk Prediction

Watch our sponsored symposium at SCCT 2022. Learn about coronary inflammation and cardiovascular disease prevention  

Read more

Quantification of Coronary Inflammation using Coronary CT Angiography to improve Patient Risk Prediction and Stratification

Join Profs. Charalambos Antoniades, Steffen Petersen and Dr. Gianluca Pontone in this European Association of Cardiovascular Imaging webinar. View here

Read more

SCCT Symposium – Beyond Plaque Assessment: Fat Attenuation Index to Personalise CV Risk Prediction

Watch our sponsored symposium with Dr Jagat Narula, Mount Sinai Hospital, Prof Ron Blankstein, Harvard Medical School, and Prof Nehal…

Read more

Anti-Inflammation Heralds the Future of CV Medicine

From CANTOS to COLCOT to COPS to LoDoCo2: Dr. Ridker presents the lessons from these trials with anti-inflammatory treatment, in…

Read more

Anti-inflammatory therapy in the prevention of cardiovascular disease

Prof. Libby discusses IL-1β as a target for atherosclerosis therapy, a strategy that was evaluated in the CANTOS trial, which…